AU2001257164A1 - Methods and compositions for the diagnosis of schizophrenia - Google Patents
Methods and compositions for the diagnosis of schizophreniaInfo
- Publication number
- AU2001257164A1 AU2001257164A1 AU2001257164A AU5716401A AU2001257164A1 AU 2001257164 A1 AU2001257164 A1 AU 2001257164A1 AU 2001257164 A AU2001257164 A AU 2001257164A AU 5716401 A AU5716401 A AU 5716401A AU 2001257164 A1 AU2001257164 A1 AU 2001257164A1
- Authority
- AU
- Australia
- Prior art keywords
- schizophrenia
- diagnosis
- compositions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19899000P | 2000-04-21 | 2000-04-21 | |
| US60198990 | 2000-04-21 | ||
| PCT/US2001/013044 WO2001082774A2 (en) | 2000-04-21 | 2001-04-23 | Methods and compositions for the diagnosis of schizophrenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001257164A1 true AU2001257164A1 (en) | 2001-11-12 |
Family
ID=22735750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001257164A Abandoned AU2001257164A1 (en) | 2000-04-21 | 2001-04-23 | Methods and compositions for the diagnosis of schizophrenia |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001257164A1 (en) |
| WO (1) | WO2001082774A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004081197A2 (en) * | 2003-03-12 | 2004-09-23 | Incyte Corporation | Immune response associated proteins |
| EP2161031A1 (en) * | 2008-09-05 | 2010-03-10 | SuppreMol GmbH | Fc gamma receptor for the treatment of B cell mediated multiple sclerosis |
-
2001
- 2001-04-23 AU AU2001257164A patent/AU2001257164A1/en not_active Abandoned
- 2001-04-23 WO PCT/US2001/013044 patent/WO2001082774A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001082774A2 (en) | 2001-11-08 |
| WO2001082774A3 (en) | 2002-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4205100A (en) | Methods and compositions for the treatment of pancreatitis | |
| AU2001231199A1 (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
| AU2001295503A1 (en) | Composition for the elimination of autoreactive b-cells | |
| AU2001271973A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
| AU2001278852A1 (en) | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis | |
| AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
| AU2002225894A1 (en) | Methods and compositions for the control of coccidiosis | |
| AU2001249444A1 (en) | Methods and compositions for the simultaneous detection of multiple analytes | |
| AU2001247196A1 (en) | Methods and compositions for detection of disease | |
| AU2001264522A1 (en) | Methods and compositions for the prevention of myopia | |
| AU2001255580A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2002249983A1 (en) | Compositions and methods for diagnosis of neuropsychiatric disorders | |
| AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
| AU2001257164A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001255597A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001255606A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257180A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257179A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001259127A1 (en) | Methods and composition for the diagnosis of schizophrenia | |
| AU2001257178A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001255589A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257176A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257175A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001259125A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
| AU2001257183A1 (en) | Methods and compositions for the diagnosis of schizophrenia |